Studies on non-thiazolidinedione antidiabetic agents. 2. Novel oxyiminoalkanoic acid derivatives as potent glucose and lipid lowering agents.
…, Y Sugiyama, H Kimura, Y Momose
Index: Imoto, Hiroshi; Sugiyama, Yasuo; Kimura, Hiroyuki; Momose, Yu Chemical and Pharmaceutical Bulletin, 2003 , vol. 51, # 2 p. 138 - 151
Full Text: HTML
Citation Number: 26
Abstract
We previously reported that (Z)-2-{4-[(5-methyl-2-phenyl-1, 3-oxazol-4-yl) methoxy] benzyloxyimino}-2-(4-phenoxyphenyl) acetic acid (3) showed potent glucose and lipid lowering effects in genetically obese and diabetic mice, KKA y. This compound also showed transcriptional activity for peroxisome proliferator-activated receptor (PPAR)-γ. We expanded on the structure–activity relationships of oxyiminoalkanoic acid derivatives based on this ...
Related Articles:
[Atobe, Masakazu; Maekawara, Naomi; Ishiguro, Noriko; Sogame, Shinya; Suenaga, Yoshihito; Kawanishi, Masashi; Suzuki, Hiroko; Jinno, Norimasa; Tanaka, Eiichi; Miyoshi, Shiro Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 7 p. 2106 - 2110]
[Hoffman, Robert V.; Kim, Hwa-Ok Journal of Organic Chemistry, 1995 , vol. 60, # 16 p. 5107 - 5113]
[Forzato, Cristina; Furlan, Giada; Nitti, Patrizia; Pitacco, Giuliana; Valentin, Ennio; Zangrando, Ennio; Buzzini, Pietro; Goretti, Marta; Turchetti, Benedetta Tetrahedron Asymmetry, 2008 , vol. 19, # 17 p. 2026 - 2036]
455. The lupin alkaloids. Part VI
[Clemo et al. Journal of the Chemical Society, 1932 , p. 2959,2965]